InvestorsHub Logo

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
Rubraquercus Free
08/15/22 7:45 AM
profile icon
HeilHiden Free
07/05/22 8:49 AM
profile icon
HeilHiden Free
07/05/22 8:43 AM
profile icon
HeilHiden Free
07/02/22 7:17 AM
profile icon
HeilHiden Free
07/01/22 3:26 PM
profile icon
HeilHiden Free
07/01/22 1:16 PM
profile icon
HeilHiden Free
07/01/22 1:08 PM
profile icon
HeilHiden Free
07/01/22 1:05 PM
profile icon
HeilHiden Free
07/01/22 12:30 PM
profile icon
HeilHiden Free
07/01/22 12:16 PM
profile icon
airman1 Free
06/03/22 11:53 AM
profile icon
dirtydozen911 Free
01/27/22 12:24 PM
profile icon
gator16 Free
01/26/22 7:31 AM
profile icon
dirtydozen911 Free
01/12/22 4:35 PM
profile icon
Hobbydigger-53 Free
09/19/21 7:20 PM
profile icon
dirtydozen911 Free
09/07/21 11:41 AM
profile icon
dirtydozen911 Free
09/07/21 11:34 AM
profile icon
big breakout Free
02/25/21 4:43 PM
profile icon
Planopenny Free
02/25/21 4:40 PM
profile icon
Planopenny Free
02/10/21 9:52 AM
profile icon
Planopenny Free
02/07/21 11:08 AM
profile icon
Planopenny Free
02/05/21 10:40 AM
profile icon
Planopenny Free
02/04/21 11:08 AM
profile icon
Fress Free
01/21/21 8:03 AM
profile icon
DayTraderOG Free
12/24/20 12:15 PM
profile icon
Planopenny Free
08/03/20 3:30 PM
profile icon
Plegee Free
06/29/20 6:58 PM
profile icon
Plegee Free
06/28/20 6:02 PM
profile icon
Plegee Free
05/07/20 6:27 PM
profile icon
sanMillion Free
05/07/20 4:58 PM
profile icon
dirtydozen911 Free
03/03/20 1:51 PM
profile icon
dirtydozen911 Free
02/12/20 12:39 PM
profile icon
ClayTrader Free
02/10/20 6:07 PM
profile icon
Plegee Free
02/07/20 7:42 AM
profile icon
eddyimano Free
02/06/20 11:51 AM

Alaunos Therapeutics Inc (TCRT) RSS Feed

Followers
82
Posters
178
Posts (Today)
0
Posts (Total)
1228
Created
08/08/06
Type
Free
Moderators

 http://www.ziopharm.com/

http://finance.yahoo.com/q/h?s=ZIOP

ZIOPHARM Oncology, Inc., a biopharmaceutical company, engages in the development and commercialization of a portfolio of in-licensed cancer drugs. It focuses primarily on the licensing and development of proprietary drug candidate families that are related to cancer therapeutics that are already on the market or in development. The company�s product candidates include ZIO-101, ZIO-201, and ZIO-301, which are in phase I and/or II studies. ZIO-101, organic arsenic is in a phase I/II trial in patients with advanced myeloma, as well as a phase I trial in advanced cancers; ZIO-201, stabilized isophosphoramide mustard is in a phase I/II trial in patients with advanced sarcoma, as well as in a phase I trials in advanced cancers; and ZIO-301, an anti-cancer agent that targets mitosis like the taxanes is in a phase I trial. ZIOPHARM was founded in 2003 and is based in New York, New York.



>

Volume:
Day Range:
Last Trade Time:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
New Post